Literature DB >> 21369966

[Registry research in dermatology].

S J Rustenbach1, K Heyer, K Reppenhagen, M Augustin.   

Abstract

Patient registries are prospective, systematic data collections, which are non-interventional (observational) in nature and reflect care practices under routine conditions. As a result, they include the most common disease characteristics (e.g. in cancer registries) and/or medical interventions (e.g. in therapy registries). The importance of registries in health services research and in clinical medicine is rapidly increasing. This is due to increasingly scarce resources in the health system and the growing need for data on benefits and efficiency. Registries permit evaluation long-term outcomes on e.g. quality of life, effectiveness as well as treatment quality. An overview of registry methodology from definitions to data analysis is given, existing registries in dermatology in Germany are summarized.

Entities:  

Mesh:

Year:  2011        PMID: 21369966     DOI: 10.1007/s00105-010-2080-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  5 in total

1.  [Memorandum registry for health services research].

Authors:  D Müller; M Augustin; N Banik; W Baumann; K Bestehorn; J Kieschke; R Lefering; B Maier; S Mathis; S J Rustenbach; S Sauerland; S C Semler; J Stausberg; H Sturm; C Unger; E A M Neugebauer
Journal:  Gesundheitswesen       Date:  2010-09-24

2.  A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics.

Authors:  Pendar Farahani; Mitchell Levine; Ron Goeree
Journal:  J Eval Clin Pract       Date:  2006-08       Impact factor: 2.431

3.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  BMJ       Date:  2007-10-20

4.  Guidelines for good pharmacoepidemiology practices (GPP).

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-02       Impact factor: 2.890

5.  Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials.

Authors:  Angela Zink; Anja Strangfeld; Matthias Schneider; Peter Herzer; Franka Hierse; Maria Stoyanova-Scholz; Siegfried Wassenberg; Andreas Kapelle; Joachim Listing
Journal:  Arthritis Rheum       Date:  2006-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.